Clinical Trials for Fallopian Tube Cancer

Find clinical trials for fallopian tube cancer. Discover research opportunities and treatment options in your area.

60 Active Trials Found

Showing 60 trials on this page

Page 2 of 3

A Beta-only IL-2 ImmunoTherapY Study

NCT ID: NCT05086692

This clinical trial, called the Beta-only IL-2 ImmunoTherapY Study, is looking to test a new treatment called MDNA11 for patients with advanced solid tumors, which are types of cancer that have spr...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Diego, California, United States, Baltimore, Maryland, United States +28 more

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT ID: NCT05429970

The PRESERVE clinical trial is exploring whether a combination of medications, specifically propranolol and etodolac, along with mind-body resilience training and music therapy, can help reduce str...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +7 more

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

NCT ID: NCT06024109

This clinical trial is investigating the effectiveness of a new type of suture called SYMMCORA® compared to a traditional suture, V-Loc®, in women undergoing laparoscopic total hysterectomy, which ...

Recruiting

Type: observational Locations: Manresa, Barcelona, Spain, Frankfurt/Main, Hessen, Germany

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT ID: NCT05281471

The OnPrime study is a clinical trial that is investigating a new treatment approach for women with certain types of ovarian cancer that have not responded well to standard chemotherapy, known as p...

Recruiting

Phase: PHASE3 Type: interventional Locations: Ann Arbor, Michigan, United States, Houston, Texas, United States +33 more

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT ID: NCT05460000

This clinical trial is investigating a new treatment approach for women with advanced high-grade ovarian cancer and related conditions, specifically looking at the effectiveness of a medication cal...

Recruiting

Phase: PHASE2 Type: interventional Locations: Leipzig, , Germany, Valencia, , Spain +44 more

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

NCT ID: NCT06469281

This clinical trial is studying a new treatment called 27T51, which is a type of immune cell therapy designed to help fight certain types of ovarian cancer, including epithelial ovarian cancer, pri...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Pittsburgh, Pennsylvania, United States +3 more

Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT ID: NCT06834672

This clinical trial is studying a new treatment called IBI354 for women with advanced ovarian, primary peritoneal, or fallopian tube cancer that has not responded to previous platinum-based chemoth...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chongqing, Chongqing, China

A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018

NCT ID: NCT04590326

This clinical trial is looking at a new drug called REGN5668 to see how safe it is and how well it works when combined with other treatments for cancers like ovarian cancer, fallopian tube cancer, ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Philadelphia, Pennsylvania, United States +29 more

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

NCT ID: NCT00005095

This clinical trial is focused on improving the early detection and prevention of ovarian cancer, particularly for women who are at higher risk. The study is collecting blood samples and health inf...

Recruiting

Type: observational Locations: Chicago, Illinois, United States

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

NCT ID: NCT05887609

This clinical trial is studying a combination of two treatments, Mirvetuximab Soravtansine (MIRV) and Olaparib, to see if they can effectively help women with certain types of recurrent ovarian can...

Recruiting

Phase: PHASE2 Type: interventional Locations: Aurora, Colorado, United States

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

NCT ID: NCT06617923

This clinical trial is studying the combination of two medications, Senaparib and Temozolomide, to see how well they work in treating certain types of ovarian cancer, specifically clear cell and en...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

NCT ID: NCT05200260

This clinical trial is exploring the best timing for surgery combined with targeted therapy for women with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal carcinoma. The goal ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Foshan, , China +7 more

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

NCT ID: NCT06342986

This clinical trial is studying a new treatment called FT536 for patients with recurrent gynecologic cancers, specifically ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. The t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Minneapolis, Minnesota, United States

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

NCT ID: NCT04701645

This clinical trial is exploring a new device called an implantable microdevice, which is designed to measure how well chemotherapy and other treatments are working directly within tumors in women ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

NCT ID: NCT05287451

This clinical trial is looking at a new approach to prevent ovarian cancer in women who have certain genetic mutations that increase their risk of this disease. Specifically, the study compares a p...

Recruiting

Phase: NA Type: interventional Locations: Saint Louis, Missouri, United States, Houston, Texas, United States +2 more

A Study of Sovilnesib in Subjects with Ovarian Cancer

NCT ID: NCT06084416

This clinical trial is studying a new medication called sovilnesib to see how safe it is and how well it works for women with advanced ovarian cancer, specifically a type called high-grade serous a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Birmingham, Alabama, United States, Little Rock, Arkansas, United States +11 more

Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer

NCT ID: NCT06735326

This clinical trial is looking at different treatment options for women with advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer who have a specific genetic mutation known as BRCA1...

Recruiting

Phase: PHASE2 Type: interventional Locations: Jinan, Shandong, China

A Biomarker Screening Protocol for Participants With Solid Tumors

NCT ID: NCT05891197

**Clinical Trial Summary: Biomarker Screening for Solid Tumors** This clinical trial is focused on a screening process that helps identify patients with specific types of solid tumors, such as adv...

Enrolling by invitation

Type: observational Locations: Rocky Mount, North Carolina, United States, Rocky Mount, North Carolina, United States

Surgery for Ovarian Cancer After PARPi Therapy in Precision

NCT ID: NCT06602063

This clinical trial is exploring a new treatment approach for women with certain types of ovarian cancer that have come back after initial treatment. Specifically, it looks at whether surgery to re...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China, Wuhan, , China

A Study of ZN-c3 in Patients With Ovarian Cancer

NCT ID: NCT04516447

This clinical trial is looking at a new treatment called ZN-c3 for women with advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer. It's a Phase 1 study, which means it's one of the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Boston, Massachusetts, United States +22 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions